Camereyes

📍 Jerusalem, Israel🗓 Founded 2015👥 1 employees💰 Last funded Oct 2016
Medical Device🌐 camereyes.com
Website LinkedIn
Diabetes is the biggest 21st century epidemic with 400 million patients worldwide. One third of the diabetic patients is expected to suffer from Diabetic Retinopathy which is the leading cause for blindness within working age adults. Early diagnosis, and proper management of retinal diseases through fundus imaging can save people’s eyesight and reduce vision loss by up to 90%. Cameryes is building an online, easy to use screening solution for Diabetic Retinopathy that can be used by primary care providers to improve management of Diabetes patients and prevent blindness.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2015
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
1
Frequently asked questions
Who invested in Camereyes?
Camereyes has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Camereyes last raise funding?
The most recent investment in Camereyes recorded on gritt.io was in October 2016.
When was Camereyes founded?
Camereyes was founded in 2015.
What industry is Camereyes in?
Camereyes operates in Medical Device. Find similar Medical Device investors on gritt.io.
Where is Camereyes based?
Camereyes is headquartered in Jerusalem, Israel.